Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of binaprofen eye drops for postoperative inflammation after cataract surgery
CTR20241979Phase 2Completed
- Sponsor
- Guangdong Zhongke Drug Research
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of binaprofen in Postoperative ocular inflammation, postoperative pain, sponsored by Guangdong Zhongke Drug Research. Started May 2024; status: completed.
02
Drugs
binaprofen
03
Conditions
Postoperative ocular inflammationpostoperative pain
Beyond the preview
Go deeper on CTR20241979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241979.